RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 40.26 Million USD | 190.03% |
| 2021 | 13.88 Million USD | -43.26% |
| 2020 | 24.46 Million USD | -80.94% |
| 2019 | 128.4 Million USD | 5.47% |
| 2018 | 121.74 Million USD | 1.9% |
| 2017 | 119.46 Million USD | 30.4% |
| 2016 | 91.61 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 6.53 Million USD | -9.85% |
| 2023 Q2 | 6.31 Million USD | -3.38% |
| 2022 Q4 | 7.24 Million USD | -2.28% |
| 2022 Q2 | 6.14 Million USD | -68.04% |
| 2022 FY | 40.26 Million USD | 190.03% |
| 2022 Q1 | 19.22 Million USD | 1042.31% |
| 2022 Q3 | 7.41 Million USD | 20.7% |
| 2021 Q3 | -6.42 Million USD | 0.0% |
| 2021 FY | 13.88 Million USD | -43.26% |
| 2021 Q4 | 1.68 Million USD | 126.18% |
| 2020 FY | 24.46 Million USD | -80.94% |
| 2019 FY | 128.4 Million USD | 5.47% |
| 2018 FY | 121.74 Million USD | 1.9% |
| 2017 FY | 119.46 Million USD | 30.4% |
| 2016 FY | 91.61 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 1650981.509% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -243.969% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 12702.228% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 66.194% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 256.078% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 83535.214% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 32506.178% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -168.451% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -1297933.527% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -311.119% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -61160.041% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 118006.296% |
| Mesoblast Limited | -35.16 Million USD | 214.493% |
| Marizyme, Inc. | 457.7 Thousand USD | -8697.209% |
| Genus plc | 178.7 Million USD | 77.468% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 81.706% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -64607.678% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -9716.781% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 366145.455% |
| ContraFect Corporation | -154 Thousand USD | 26246.104% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 80630.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -52355.023% |
| IMV Inc. | -962.29 Thousand USD | 4284.255% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 10490.941% |
| MultiCell Technologies, Inc. | 49.32 USD | -81640208.191% |
| ONE Bio Corp. | 20.12 Million USD | -100.07% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -82241.513% |
| Q BioMed Inc. | -8988.00 USD | 448086.204% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -42.506% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 261154.201% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 9.227% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 3627.154% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -57421.429% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 813205.816% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -28558.363% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 41391.083% |
| GB Sciences, Inc. | -624.00 USD | 6452824.359% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 46904.529% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.467% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 19358273.077% |
| Enzolytics Inc. | 30.7 Thousand USD | -131022.183% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -8246.237% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 96.368% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 7925.893% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -6421.873% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 90.169% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 454763.505% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 48120.847% |
| Kadimastem Ltd | -630.13 Thousand USD | 6489.87% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -3975.483% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -318.947% |
| BioStem Technologies, Inc. | 15.42 Million USD | -161.04% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 340319.687% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -22705.279% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -22705.279% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -2866.894% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 138944.828% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -8846.923% |
| SYBLEU INC | 11.69 Thousand USD | -344162.996% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -773.806% |
| Bioxytran, Inc. | -8285.00 USD | 486098.793% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 10894.906% |
| Neutra Corp. | 14.33 Thousand USD | -280785.943% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 49203.659% |
| PureTech Health plc | -1.6 Million USD | 2611.853% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 4121.529% |
| IXICO plc | 3.27 Million USD | -1131.346% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 5901.873% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 2348.185% |
| CSL Limited | 7.7 Billion USD | 99.477% |
| Cellectis S.A. | 18 Thousand USD | -223594.444% |